Literature DB >> 26836154

Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.

Mariacristina Siotto1, Ilaria Simonelli2, Patrizio Pasqualetti3, Stefania Mariani2, Deborah Caprara2, Serena Bucossi4, Mariacarla Ventriglia2,5, Rossana Molinario6, Mirca Antenucci6, Mauro Rongioletti7, Paolo Maria Rossini4,8, Rosanna Squitti2,5.   

Abstract

Meta-analyses demonstrate copper involvement in Alzheimer's disease (AD), and the systemic ceruloplasmin status in relation to copper is an emerging issue. To deepen this matter, we evaluated levels of ceruloplasmin concentration, ceruloplasmin activity, ceruloplasmin specific activity (eCp/iCp), copper, non-ceruloplasmin copper iron, transferrin, the ceruloplasmin/transferrin ratio, and the APOE genotype in a sample of 84 AD patients and 58 healthy volunteers. From the univariate logistic analyses we found that ceruloplasmin concentration, eCp/iCp, copper, transferrin, the ceruloplasmin/transferrin ratio, and the APOE genotype were significantly associated with the probability of AD. In the multivariable logistic regression analysis, we selected the best subset of biological predictors by the forward stepwise procedure. The analysis showed a decrease of the risk of having AD for eCp/iCp (p = 0.001) and an increase of this risk for non-ceruloplasmin copper (p = 0.008), age (p = 0.001), and APOE-ɛ4 allele (p <  0.001). The estimated model showed a good power in discriminating AD patients from healthy controls (area under curve: 88% ; sensitivity: 66% ; specificity 93%). These data strength the breakdown of copper homeostasis and propose eCp/iCp as a reliable marker of ceruloplasmin status.

Entities:  

Keywords:  Alzheimer’s disease; ceruloplasmin; ceruloplasmin specific activity; non-ceruloplasmin copper

Mesh:

Substances:

Year:  2016        PMID: 26836154     DOI: 10.3233/JAD-150611

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

1.  An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain.

Authors:  Mariacristina Siotto; Irene Aprile; Ilaria Simonelli; Costanza Pazzaglia; Mariacarla Ventriglia; Massimo Santoro; Isabella Imbimbo; Rosanna Squitti; Luca Padua
Journal:  J Neural Transm (Vienna)       Date:  2017-10-30       Impact factor: 3.575

2.  Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein.

Authors:  Courtney J McCann; Samuel Jayakanthan; Mariacristina Siotto; Nan Yang; Maria Osipova; Rosanna Squitti; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-19       Impact factor: 4.526

3.  Comprehensive Proteomic Profiling of Urinary Exosomes and Identification of Potential Non-invasive Early Biomarkers of Alzheimer's Disease in 5XFAD Mouse Model.

Authors:  Zhiqi Song; Yanfeng Xu; Ling Zhang; Li Zhou; Yu Zhang; Yunlin Han; Xianglei Li; Pin Yu; Yajin Qu; Wenjie Zhao; Chuan Qin
Journal:  Front Genet       Date:  2020-11-05       Impact factor: 4.599

4.  Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology.

Authors:  Ibrahima Diouf; Ashley I Bush; Scott Ayton
Journal:  Neurobiol Dis       Date:  2020-02-19       Impact factor: 5.996

5.  Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.

Authors:  Keith W VanDusen; Yi-Ju Li; Victor Cai; Ashley Hall; Sarah Hiles; J Will Thompson; M Arthur Moseley; Mary Cooter; Leah Acker; Jerrold H Levy; Kamrouz Ghadimi; Quintin J Quiñones; Michael J Devinney; Stacey Chung; Niccolò Terrando; Eugene W Moretti; Jeffrey N Browndyke; Joseph P Mathew; Miles Berger
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?

Authors:  Rosanna Squitti; Armando J Mendez; Ilaria Simonelli; Camillo Ricordi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

8.  Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.

Authors:  Rosanna Squitti; Carlo Salustri; Mauro Rongioletti; Mariacristina Siotto
Journal:  Front Neurol       Date:  2017-09-25       Impact factor: 4.003

9.  Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies.

Authors:  Dan-Dan Li; Wei Zhang; Zhan-You Wang; Pu Zhao
Journal:  Front Aging Neurosci       Date:  2017-09-15       Impact factor: 5.750

10.  Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Ilaria Simonelli; Cristian Bonvicini; Alfredo Costa; Giulia Perini; Giuliano Binetti; Luisa Benussi; Roberta Ghidoni; Giacomo Koch; Barbara Borroni; Alberto Albanese; Stefano L Sensi; Mauro Rongioletti
Journal:  Biomolecules       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.